Evolent Health, Inc.
EVH
$2.99
-$0.07-2.29%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.88B | 2.05B | 2.20B | 2.40B | 2.55B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.88B | 2.05B | 2.20B | 2.40B | 2.55B |
| Cost of Revenue | 1.48B | 1.68B | 1.84B | 2.03B | 2.19B |
| Gross Profit | 399.88M | 378.34M | 359.26M | 365.72M | 367.35M |
| SG&A Expenses | 288.48M | 273.61M | 261.42M | 254.55M | 246.62M |
| Depreciation & Amortization | 115.85M | 78.51M | 84.60M | 91.33M | 96.77M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.88B | 2.03B | 2.18B | 2.38B | 2.53B |
| Operating Income | -4.45M | 26.22M | 13.25M | 19.84M | 23.96M |
| Income Before Tax | -534.64M | -127.75M | -131.55M | -109.47M | -63.04M |
| Income Tax Expenses | -126.00K | 430.00K | -1.10M | -508.00K | -1.41M |
| Earnings from Continuing Operations | -534.51 | -128.18 | -130.45 | -108.96 | -61.62 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -534.51M | -128.18M | -130.45M | -108.96M | -61.62M |
| EBIT | -4.45M | 26.22M | 13.25M | 19.84M | 23.96M |
| EBITDA | 88.20M | 80.93M | 73.34M | 85.57M | 95.13M |
| EPS Basic | -4.95 | -1.67 | -1.70 | -1.32 | -0.91 |
| Normalized Basic EPS | -0.60 | -0.36 | -0.39 | -0.33 | 0.01 |
| EPS Diluted | -4.95 | -1.67 | -1.70 | -1.32 | -0.91 |
| Normalized Diluted EPS | -0.60 | -0.36 | -0.39 | -0.33 | 0.01 |
| Average Basic Shares Outstanding | 456.88M | 460.30M | 461.09M | 459.90M | 458.72M |
| Average Diluted Shares Outstanding | 456.88M | 460.30M | 461.09M | 459.90M | 458.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -2.08% | -12.43% | -14.67% | -17.97% | -32.59% |